Accelerate oncology breakthroughs.

Next-generation therapies bring the promise of better outcomes for cancer patients.  But with new discoveries come a more complex development path and more unknowns. We are here to connect your oncology program with solutions to support your success.

Your scientific breakthroughs deserve a new approach to development

By making intelligent connections, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed. IQVIA helps you

  • Integrate biomarker strategies, operations and partners from development plans through trial execution
  • Design and execute adaptive and novel trial designs
  • Use patient insights to improve trial design, speed recruitment and reduce patient burden
  • Plan and execute cell and gene therapy programs with specialized expertise and resources 
  • Optimize development plans by applying real world and commercial insights in clinical strategies and forecasting scenarios
  • Apply AI and machine learning to improve trial efficiency and patient safety
Man in jacket in office

11 oncology approvals within 12 months

Oncology market approvals supported by IQVIA, August 2019-2020

cancer patient with family

Early phase oncology

Oncology drug development is moving from drug-centered to patient-centered. From dose escalation through dose optimization, IQVIA’s teams are here to help you navigate the evolving landscape and make informed decisions quickly.

  • 690+ Phase I-II studies since 2016
  • Dedicated clinical and operational experts for trial design strategy and execution
  • Technology solutions for enhanced cohort planning and management
  • Established global network of qualified Phase I oncology sites working in close alignment for fast site activation and better patient recruitment
  • Modeling and simulation of multiple datasets to identify optimal dose of targeted therapies
  • End to end laboratory services from Q2 Solutions for biomarker services, assay validation and development of companion diagnostics
illuminated cells

IQVIA's Oncology Insights Center

Discover the latest topics, trends and scientific developments that are relevant to your oncology program.  Read white papers, articles, webinars and more.
meeting around tablet

Leverage the power of real world data

Through advanced analytics, such as artificial intelligence and machine learning, coupled with our oncology expertise, IQVIA Oncology Commercial Solutions can help track the impact of clinical advancements in real world diagnosis and treatment patterns. By accelerating time to insights we help customers drive business decisions which, ultimately, impact patient care. 

Related solutions

Explore More

Contact Us